| Literature DB >> 35936522 |
Hassan Ebrahimpour Sadagheyani1, Rahim Sharafkhani2, Shahriar Sakhaei3, Hamid Jafaralilou4, Parviz Shahmirzalou2.
Abstract
Background: Beta Thalassemia Trait (BTT) and Iron Deficiency Anemia (IDA) were two common clinical problems with clinical hypochromic and microcytic manifestations, and their differentiation from each other was very important and needs innovative formulas and laboratory tests. Since the consideration of anemia as a pair with BTT leads to beta-thalassemia major birth in 25% of cases, offering prospective parents detailed information about the likelihood of their offspring developing BTT is essential. The present study aimed to investigate the performance of common equations in differentiation of BTT from IDA.Entities:
Keywords: Anemia; Differentiation equation; Mentzer index; Red blood cell; Thalassemia
Year: 2022 PMID: 35936522 PMCID: PMC9288402 DOI: 10.18502/ijph.v51i4.9255
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.479
Fig. 1:The study selection flow diagram
Equation of differentiation of BTT from IDA along with reference and cutoff point of the BTT
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 1 | Matos-Carvalho (M&K) (13) | (1.91×RBC)+(0.44×MCHC) (>23.85) | 11 | Green&King (G&K) (24) | (MCV2*RDW)/)Hb *100) (<72) |
| 2 | Srivastava(Sriv) (16) | MCH/RBC (<3.8) | 12 | KandhroI (Kan.I)(25) | (RBC/HCT+0.5×RDW) (cutoff<8.2) (17) |
| 3 | Shine&Lal (SH&L) (17) | MCV2*MCH*0/01 (<1530) | 13 | Kandhro II(Kan.II) (25) | RDW*5/RBC (<16.8) |
| 4 | KermanI (Ker.I) (18) | MCV*MCH/RBC (<300) | 14 | Sirdah (26) | MCV-RBC-(3 × Hb) (<27) |
| 5 | KermanII(Ker.II) (18) | Ker.I *10/MCHC (<85) | 15 | Sirachainan (Sir) (27) | 1.5×Hb-0.05*MCV (cutoff>14) |
| 6 | RDW (19) | MCV* RDW/RBC (<220) | 16 | Bordbar (28) | (|80-MCV|×|27-MCH|) (>44.76) |
| 7 | Mentzer (Men) (20) | MCV/RBC(<13) | 17 | Keikhaei(Kei) (29) | )Hb×RDW×100(/(RBC2×MCHC) (<21) |
| 8 | Ricerca(Ric) (21) | (RDW/RBC) (<3.3 | 18 | Huber-Herklotz (H&H )(30) | (MCH×RDW×0.1/RBC)+ RDW (cutoff<22) (23) |
| 9 | Ehsani (Eh) (22) | MCV-(10×RBC) (<15) | 19 | Zaghloul(Z.I) (31) | Hb+Hct+RBC(Males>55.7, Females> 51.6) |
| 10 | England&Fraser(E&F) (23) | MCV-RBC-(5*Hb)-3.4 (<0) | 20 | Zaghloul(Z.II) (31) | Hb+Hct+RBC–RDW (Males>40.4, Females> 35.6) |
Definition of basic Indices
|
|
|
|
|---|---|---|
| 1 | Sensitivity (SEN) | TP/TP+FN× 100 |
| 2 | Specificity (Spe) | TN/TN+FP× 100 |
| 3 | Positive Likelihood Ratio (PLR) | SEN / (1−SPE) |
| 4 | Negative Likelihood Ratio (NLR) | (1−SEN) / SPE |
| 5 | Youden Index (Y.I) | (SEN+SPE) – 1 |
| 6 | Accuracy (Acc) | (TP+TN) / (TP+TN+FP+FN) |
| 7 | Positive Predictive Value (PPV | TP / TP+FP × 100 |
| 8 | Negative Predictive Value (NPV ) | TN / TN+ FN × 100 |
Demographic characteristics of study samples
|
|
|
| ||
|---|---|---|---|---|
|
| ||||
| BTT: 73(25) | IDA:219(75) | |||
| Sex | Male | 42(28.58) | 105(71.42) | 147(50.34) |
| Female | 31(21.37) | 114(78.63) | 145(49.66) | |
| Education | Primary | 35(26.92) | 95(73.08) | 130(44.52) |
| Secondary | 25(25.00) | 75(75.00) | 100(34.25) | |
| University | 13(20.97) | 49(79.03) | 62(21.25) | |
| Family marriage | Yes | 13(32.50) | 27(67.50) | 40(13.70) |
| No | 60(23.81) | 192(76.19) | 252(86.30) | |
| Residents | City | 20(13.33) | 130(86.67) | 150(51.37) |
| Village | 53(37.32) | 89(62.68) | 142(48.63) | |
Mean ± standard deviation of blood-related indices of the overall, BTT & IDA as well as sex groups.
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Males | Female |
| Overall | Males | Females |
| Overall | |||
| RBC | 5.63±0.71 | 6.44±.83 | 5.71±.43 | <0.001 | 6.13±.77 | 5.91±.46 | 5.09±.49 | <0.001 | 5.48±.63 | <0.001 |
| HGB | 13.4±1.91 | 13.25±1.11 | 11.51±1.02 | <0.001 | 12.51±1.37 | 15.07±1.52 | 12.52±1.48 | <0.001 | 13.74±1.97 | <0.001 |
| HCT | 42.23±4.58 | 43.89±3.34 | 38.20±2.81 | <0.001 | 41.46±4.20 | 45.60±3.42 | 39.63±3.75 | <0.001 | 42.48±4.67 | 0.112 |
| MCV* | 75.11±7.10 | 68.28±6.67 | 67.25±4.83 | 0.772 | 67.83±5.93 | 77.45±4.91 | 77.59±6.33 | 0.453 | 77.52±5.69 | <0.001 |
| MCH* | 23.99±3.19 | 20.69±2.54 | 20.41±2.15 | 0.877 | 20.57±2.37 | 25.62±2.62 | 24.68±2.45 | 0.001 | 25.13±2.57 | <0.001 |
| MCHC | 31.76±2.12 | 30.20±1.27 | 30.15±1.67 | 0.864 | 30.18±1.44 | 33.01±2.08 | 31.59±1.79 | <0.001 | 32.26±2.06 | <0.001 |
| RDW* | 14.70±2.46 | 15.65±1.73 | 15.88±1.50 | 0.487 | 15.75±1.63 | 14.15±3.00 | 14.58±2.14 | 0.003 | 14.37±2.59 | <0.001 |
| HbA2* | 3.17±1.39 | 5.16±.90 | 4.93±1.28 | 0.340 | 5.06±1.07 | 2.68±.88 | 2.42±.66 | 0.004 | 2.53±.78 | <0.001 |
P: P-value *: Mann-Whitney test of Means and others t-test
Diagnostic values twenty differential indices.
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bor | 0.841(0.780–0.902) | 0.791 | 0.885 | 0.695 | 0.927 | 6.903 | 0.235 | 0.862 | 0.676 |
| 2 | Ker.I | 0.838(0.780–0.896) | 0.843 | 0.834 | 0.621 | 0.943 | 5.103 | 0.188 | 0.836 | 0.677 |
| 3 | Ker.II | 0.836(0.772–0.899) | 0.765 | 0.907 | 0.722 | 0.924 | 8.258 | 0.259 | 0.873 | 0.672 |
| 4 | Sriv | 0.830(.769–.894) | 0.786 | 0.885 | 0.687 | 0.927 | 6.851 | 0.242 | 0.861 | 0.671 |
| 5 | Eh | 0.821(0.759–0.882) | 0.814 | 0.834 | 0.612 | 0.933 | 4.930 | 0.222 | 0.829 | 0.649 |
| 6 | Men | 0.788(0.725–0.851) | 0.814 | 0.770 | 0.532 | 0.928 | 3.550 | 0.240 | 0.781 | 0.584 |
| 7 | Sh-L | 0.780 (0.725–.842) | 0.888 | 0.669 | 0.470 | 0.948 | 2.691 | 0.165 | 0.724 | 0.558 |
| 8 | Sirdah | 0.683(0.610–0.756) | 0.691 | 0.674 | 0.398 | 0.875 | 2.122 | 0.457 | 0.678 | 0.365 |
| 9 | Kei | 0.630(0.560–0.700) | 0.897 | 0.362 | 0.308 | 0.917 | 1.407 | 0.283 | 0.491 | 0.259 |
| 10 | RDW | 0.586(0.513–0.659) | 0.911 | 0.260 | 0.280 | 0.903 | 1.232 | 0.338 | 0.416 | 0.172 |
| 11 | G-K | 0.577(0.504–0.651) | 0.926 | 0.227 | 0.275 | 0.907 | 1.199 | 0.322 | 0.395 | 0.154 |
| 12 | E-F | 0.570(0.493–0.647) | 0.647 | 0.495 | 0.285 | 0.818 | 1.282 | 0.712 | 0.531 | 0.142 |
| 13 | Kan.II | 0.556(0.482–0.630) | 1 | 0.111 | 0.262 | 1 | 1.125 | 0 | 0.325 | 0.111 |
| 14 | Ric | 0.556(0.482–0.630) | 1 | 0.111 | 0.263 | 1 | 1.125 | 0 | 0.325 | 0.111 |
| 15 | Matos | 0.544(0.467–0.621) | 0.808 | 0.282 | 0.262 | 0.824 | 1.127 | 0.676 | 0.408 | 0.091 |
| 16 | Huber | 0.520(0.442–0.598 | 0.794 | 0.246 | 0.250 | 0.791 | 1.053 | 0.835 | 0.378 | 0.040 |
| 17 | Z.II | 0.512(0.434–0.590 ) | 0.926 | 0.097 | 0.245 | 0.807 | 1.026 | 0.752 | 0.296 | 0.024 |
| 18 | Z.I | 0.510(0.432–0.588) | 0.941 | 0.082 | 0.242 | 0.818 | 1.025 | 0.712 | 0.286 | 0.023 |
| 19 | Sir | 0.420(0.339–0.501) | 0.691 | 0.151 | 0.203 | 0.611 | 0.814 | 2.040 | 0.279 | −0.157 |
| 20 | Kan.I | 0.378(0.297–0.459) | 0.602 | 0.153 | 0.183 | 0.550 | 0.712 | 2.586 | 0.261 | −0.243 |
M:Males; F:Females
Fig. 2:Roc Curves of blood indices